Home   »  TRADE TOPICS  »  Prescription Drugs  »  Trans Pacific Partnership

State and Consumer Opposition to Trade Agreement Restrictions on
Pharmaceutical Reimbursement and Pricing Programs

State officials and consumer organizations are opposed to the pharmaceutical industry agenda to insert new international trade law restrictions on the operation of government pharmaceutical reimbursement programs and other measures that restrain the excessive prices of brand name medicines.

Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap